These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31261194)

  • 1. Prenatal Opioid Maintenance in the United States and Its Effect on Neonatal Abstinence Syndrome: The Case of West Virginia's Opioid Epidemic.
    Ruley M; Coustasse A
    Health Care Manag (Frederick); 2019; 38(3):258-266. PubMed ID: 31261194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine: a new player in neonatal withdrawal syndrome.
    Nanda S; Brant R; Regier M; Yossuck P
    W V Med J; 2015; 111(1):16-21. PubMed ID: 25665273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
    O'Connor AB; Collett A; Alto WA; O'Brien LM
    J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero.
    Lawlor ML; Shook LA; McQuerry K; Srinivasan A; Johnson QB; Chavan NR; Critchfield AS
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2718-2722. PubMed ID: 30563376
    [No Abstract]   [Full Text] [Related]  

  • 5. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine.
    O'Connor AB; Kelly BK; O'Brien LM
    Drug Alcohol Depend; 2017 Nov; 180():200-203. PubMed ID: 28917206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care.
    Pryor JR; Maalouf FI; Krans EE; Schumacher RE; Cooper WO; Patrick SW
    Arch Dis Child Fetal Neonatal Ed; 2017 Mar; 102(2):F183-F187. PubMed ID: 28073819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripartum Anesthetic Management of the Opioid-tolerant or Buprenorphine/Suboxone-dependent Patient.
    Pan A; Zakowski M
    Clin Obstet Gynecol; 2017 Jun; 60(2):447-458. PubMed ID: 28426507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study on buprenorphine use during pregnancy: effects on maternal and neonatal outcome.
    Kahila H; Saisto T; Kivitie-Kallio S; Haukkamaa M; Halmesmäki E
    Acta Obstet Gynecol Scand; 2007; 86(2):185-90. PubMed ID: 17364281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic management of the opioid neonatal abstinence syndrome.
    Kraft WK; van den Anker JN
    Pediatr Clin North Am; 2012 Oct; 59(5):1147-65. PubMed ID: 23036249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal Abstinence Syndrome in West Virginia Substate Regions, 2007-2013.
    Stabler ME; Long DL; Chertok IR; Giacobbi PR; Pilkerton C; Lander LR
    J Rural Health; 2017 Jan; 33(1):92-101. PubMed ID: 26879950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with the prevalence of neonatal abstinence syndrome in West Virginia.
    Rogerson T; Houston A; Lyman G; Ogden J; Paschall K; Penaranda M; Rios A; Wetzel R; Horzempa J
    J Opioid Manag; 2018; 14(6):445-452. PubMed ID: 30629281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal buprenorphine treatment and infant outcome.
    Jansson LM; Velez ML; McConnell K; Spencer N; Tuten M; Jones H; Rios R; King VL; Gandotra N; Millio L; DiPietro JA
    Drug Alcohol Depend; 2017 Nov; 180():56-61. PubMed ID: 28869859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autonomous Care Pathway to Patient Opioid Abstinence: Should All Programs Offer this Approach?
    Patel A; Dietz P; Casto A; DePond J; Taylor L; Seybold D; Blake A; Calhoun B
    Issues Law Med; 2021; 36(2):193-210. PubMed ID: 36629776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of opioid dependence in the setting of pregnancy.
    Young JL; Martin PR
    Psychiatr Clin North Am; 2012 Jun; 35(2):441-60. PubMed ID: 22640765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
    Debelak K; Morrone WR; O'Grady KE; Jones HE
    Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
    Johnson S; Martin PR
    Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between gestational age and the severity of neonatal abstinence syndrome.
    Gibson KS; Stark S; Kumar D; Bailit JL
    Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of buprenorphine in pregnancy: patient management and effects on the neonate.
    Johnson RE; Jones HE; Fischer G
    Drug Alcohol Depend; 2003 May; 70(2 Suppl):S87-101. PubMed ID: 12738353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.